Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,958,216
+$138,658 QoQ
Shares Held
12,495
+4.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#438
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ellevest, Inc. holds $19,452,346 across 14 Drug Manufacturers - General names. NVS ranks #4 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,180 | $3,814,187 | |
| 2 | MRK |
Merck & Co., Inc.
|
23,926 | $3,074,491 | |
| 3 | JNJ |
Johnson & Johnson
|
50,449 | $2,009,847 | |
| 4 | NVS |
Novartis AG
This page
|
12,495 | $1,958,216 | |
| 5 | AZN |
Astrazeneca PLC
|
6,725 | $1,275,194 | |
| 6 | PFE |
Pfizer Inc
|
45,568 | $1,097,277 | |
| 7 | AMGN |
Amgen Inc
|
2,956 | $1,070,426 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,309 | $1,049,759 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,958,216 | 12,495 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,819,558 | 11,912 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,367,256 | 9,917 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,286,503 | 10,032 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,276,050 | 10,545 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,241,552 | 11,137 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,554,040 | 15,970 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,104,405 | 18,296 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,937,784 | 18,202 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,571,862 | 16,250 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,521,920 | 15,073 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,490,008 | 14,628 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,285,795 | 12,742 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,051,560 | 11,430 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $936,684 | 10,325 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $452,867 | 5,958 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $913,262 | 10,804 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $783,607 | 8,930 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $640,280 | 7,320 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $618,256 | 7,560 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $536,491 | 5,880 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $429,024 | 5,019 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $389,240 | 4,122 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $252,531 | 2,904 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $250,229 | 2,865 | Shares | Sole | 2020-07-06 | |
| 2020-03-31 | $139,917 | 1,697 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||